Company Profile
AvansCure provide global sourcing and international marketing expertise services to pharmaceutical, biotech and medical devices companies in the area of Active Pharmaceutical Ingredients (APIs), formulations, biological products, chemicals and intermediates. Over the recent years we have established excellent relationships with a mix of companies specializing both in the research and manufacture of ingredients for pharmaceutical applications.
VIEW MORE VIEW LESSProduct List
| Product Name | Synonyms | CAS No. | Grate/Content | Operate |
|---|---|---|---|---|
Bosentan hydrate |
Benzenesulfonamide,4-(1,1-dimethylethyl)-N-[6-(2-hydroxyethoxy)-5-(2-methoxyphenoxy)[2,2′-bipyrimidin]-4-yl]-,hydrate (1:1);Benzenesulfonamide,4-(1,1-dimethylethyl)-N-[6-(2-hydroxyethoxy)-5-(2-methoxyphenoxy)[2,2′-bipyrimidin]-4-yl]-,monohydrate;Bosentan hydrate;Bosentan monohydrate;Stayveer |
157212-55-0 | Inquiry | |
Cancidas |
Caspofungin acetate;(3S,6S,9S,11R,15S,18S,20R,21S,24S,25S)-21-(2-Aminoethylamino)-3-[3-amino-1(R)-hydroxypropyl]-6-[1(S),2(S)-dihydroxy-2-(4-hydroxyphenyl)ethyl]-18-(10,12-dimethyltetradecanamido)-11,20,25-trihydroxy-15-[1(R)-hydroxyethyl]-1,4,7,13,16,22-hexaazatricyclo[22.3.0.0(9,13)]heptacosane-2,5,8,14,17,23-hexaone diacetate;Cancidas;L 743,872;L 743872;L-743,872;L-743872;Mk 0991 |
179463-17-3 | Inquiry | |
Ceftibuten dihydrate |
5-Thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid,7-[[(2Z)-2-(2-amino-4-thiazolyl)-4-carboxy-1-oxo-2-buten-1-yl]amino]-8-oxo-,hydrate (1:2),(6R,7R)-;5-Thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid,7-[[2-(2-amino-4-thiazolyl)-4-carboxy-1-oxo-2-butenyl]amino]-8-oxo-,dihydrate,[6R-[6α,7β(Z)]]-;(6R,7R)-7-[[(2Z)-2-(2-Amino-4-thiazolyl)-4-carboxy-1-oxo-2-buten-1-yl]amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid hydrate (1:2) |
118081-34-8 | Inquiry | |
Doxorubicin hydrochloride |
5,12-Naphthacenedione,10-[(3-amino-2,3,6-trideoxy-α-L-lyxo-hexopyranosyl)oxy]-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(2-hydroxyacetyl)-1-methoxy-,hydrochloride (1:1),(8S,10S)-;Adriamycin,hydrochloride;5,12-Naphthacenedione,10-[(3-amino-2,3,6-trideoxy-α-L-lyxo-hexopyranosyl)oxy]-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxy-,hydrochloride,(8S-cis)-;5,12-Naphthacenedione,10-[(3-amino-2,3,6-trideoxy-α-L-lyxo-hexopyranosyl)oxy]-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxy-,hydrochloride,(8S,10S)-;Doxorubicin hydrochloride;Adriamycin;Adriacin;Adriblastina RD;Adriblastina;Adriblastin;ADR;DOX HCl;FI 6804;ADM hydrochloride;Hydroxydaunorubicin hydrochloride;FI 106;Adriablastina CS;Lipo-Dox;Adrosal;Ameisu hydrochloride;Myocet liposomal;Doxolipad;Caelyx pegylated liposomal;Doxorubicin-TEVA;Doxorubicin-LANS |
25316-40-9 | Inquiry | |
Fingolimod hydrochloride |
1,3-Propanediol,2-amino-2-[2-(4-octylphenyl)ethyl]-,hydrochloride (1:1);1,3-Propanediol,2-amino-2-[2-(4-octylphenyl)ethyl]-,hydrochloride;FTY 720;Fingolimod hydrochloride;2-Amino-2-[2-(4-octylphenyl)ethyl]propane-1,3-diol hydrochloride;Gilenya;Imusera;2-Amino-[2-(4-octylphenyl)ethyl]-1,3-propanediol hydrochloride |
162359-56-0 | Inquiry |